129 related articles for article (PubMed ID: 37903299)
1. Comparing a Data Entry Tool to Provider Insights Alone for Assessment of COVID-19 Hospitalization Risk: Pilot Matched Cohort Comparison Study.
Yahya G; O'Keefe JB; Moore MA
JMIR Form Res; 2023 Nov; 7():e44250. PubMed ID: 37903299
[TBL] [Abstract][Full Text] [Related]
2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
3. Use of a Telemedicine Risk Assessment Tool to Predict the Risk of Hospitalization of 496 Outpatients With COVID-19: Retrospective Analysis.
O'Keefe JB; Tong EJ; Taylor TH; O'Keefe GAD; Tong DC
JMIR Public Health Surveill; 2021 Apr; 7(4):e25075. PubMed ID: 33667174
[TBL] [Abstract][Full Text] [Related]
4. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
7. Determining Post-COVID-19 Symptoms and Rehabilitation Needs in Hospitalized and Nonhospitalized COVID-19 Survivors with Tele-Assessment Methods.
Yilmaz Gokmen G; Durmaz D; Demir C; Yilmaz FN
Telemed J E Health; 2023 Sep; 29(9):1312-1323. PubMed ID: 36757300
[No Abstract] [Full Text] [Related]
8. Health Care Utilization and Clinical Characteristics of Nonhospitalized Adults in an Integrated Health Care System 28-180 Days After COVID-19 Diagnosis - Georgia, May 2020-March 2021.
Hernandez-Romieu AC; Leung S; Mbanya A; Jackson BR; Cope JR; Bushman D; Dixon M; Brown J; McLeod T; Saydah S; Datta D; Koplan K; Lobelo F
MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(17):644-650. PubMed ID: 33914727
[TBL] [Abstract][Full Text] [Related]
9. Analysis of All-Cause Hospitalization and Death Among Nonhospitalized Patients With Type 2 Diabetes and SARS-CoV-2 Infection Treated With Molnupiravir or Nirmatrelvir-Ritonavir During the Omicron Wave in Hong Kong.
Lui DTW; Chung MSH; Lau EHY; Lau KTK; Au ICH; Lee CH; Woo YC; Wong CKH; Cowling BJ
JAMA Netw Open; 2023 May; 6(5):e2314393. PubMed ID: 37204790
[TBL] [Abstract][Full Text] [Related]
10. Managing COVID-19 With a Clinical Decision Support Tool in a Community Health Network: Algorithm Development and Validation.
McRae MP; Dapkins IP; Sharif I; Anderman J; Fenyo D; Sinokrot O; Kang SK; Christodoulides NJ; Vurmaz D; Simmons GW; Alcorn TM; Daoura MJ; Gisburne S; Zar D; McDevitt JT
J Med Internet Res; 2020 Aug; 22(8):e22033. PubMed ID: 32750010
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Hospitalized and Nonhospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, November 2019.
Chatham-Stephens K; Roguski K; Jang Y; Cho P; Jatlaoui TC; Kabbani S; Glidden E; Ussery EN; Trivers KF; Evans ME; King BA; Rose DA; Jones CM; Baldwin G; Delaney LJ; Briss P; Ritchey MD; ;
MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(46):1076-1080. PubMed ID: 31751326
[TBL] [Abstract][Full Text] [Related]
12. Oral health in hospitalized and nonhospitalized community-dwelling elderly patients.
Pajukoski H; Meurman JH; Snellman-Gröhn S; Sulkava R
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Oct; 88(4):437-43. PubMed ID: 10519751
[TBL] [Abstract][Full Text] [Related]
13. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
[TBL] [Abstract][Full Text] [Related]
14. Patient and provider perspectives of a new prenatal care model introduced in response to the coronavirus disease 2019 pandemic.
Peahl AF; Powell A; Berlin H; Smith RD; Krans E; Waljee J; Dalton VK; Heisler M; Moniz MH
Am J Obstet Gynecol; 2021 Apr; 224(4):384.e1-384.e11. PubMed ID: 33039393
[TBL] [Abstract][Full Text] [Related]
15. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
16. Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial.
Gupta A; Gonzalez-Rojas Y; Juarez E; Crespo Casal M; Moya J; Rodrigues Falci D; Sarkis E; Solis J; Zheng H; Scott N; Cathcart AL; Parra S; Sager JE; Austin D; Peppercorn A; Alexander E; Yeh WW; Brinson C; Aldinger M; Shapiro AE;
JAMA; 2022 Apr; 327(13):1236-1246. PubMed ID: 35285853
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of Hospitalized Pediatric Coronavirus Disease 2019 Cases in Chicago, Illinois, March-April 2020.
Mannheim J; Gretsch S; Layden JE; Fricchione MJ
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):519-522. PubMed ID: 32479632
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
